Eletriptan intermediate_Viwit

Product

/

Products and Services

/

Active pharmaceutical ingredients

/

/

Eletriptan intermediate

News Center

Viwit Pharmaceutical Co., Ltd. participated in CPHI Worldwide 2022 held in Frankfurt Germany from November 1st to November 3rd. 2022-11-09 12:43:00

As the world's largest pharmaceutical industry exhibition, CPHI has been successfully held for 30 years. It displays the entire pharmaceutical supply chain, from API, P-MEC to FDF. It becomes the largest annual gathering of pharmaceutical professionals all over the world. Viwit met old friends and new business partners at CPHI. We displayed a wonderful enterprise image with our products and services, and promoted our international business through CPHI.

Viwit participants in CPhI China 2019, booth: W2B28 2019-06-18 01:34:00

CPhI China 2019 will be held at Shanghai New International Expo Center on June 18-20, 2019. Welcome to patronage of Viwit, booth number: W2B28. If you would like to make an appointment in advance, please email us at service@viwit.com.

CPhI India 2018, Booth No. 4.H15 2018-12-12 01:34:00

CPhI India 2018, Booth No. 4.H15 CPhI India 2018 will take place on Dec. 12 - Dec. 14, 2018 at India Expo Center, India. Please visit us on CPhI India 2018, Booth No. 4.H15. If you would like to make an appointment, please send an e-mail to service@viwit.com.

Welcome participants in CPhI India 2018, booth number: 4.H15 2018-12-12 01:32:00

Welcome participants in CPhI India 2018, booth number: 4.H15 CPhI India 2018 will be held from December 12th to 14th, 2018 at the Expo Center in Delhi, India. Welcome to patronage of Viwit, booth number: 4.H15. If you want to make an appointment in advance, please send an email to service@viwit.com

Congratulations to Viwit Pharmaceutical Co., Ltd. for passing GMP certification of Health Canada 2018-10-11 01:32:00

In September 2018, Viwit's API factory in Tengzhou, Shandong Province ushered in a five-day GMP audit by Health Canada. In the end, Welcome successfully completed the GMP inspection by Health Canada and achieved excellent results. Any regulatory inspection is a challenge, but it is also a great opportunity to demonstrate your capabilities. Viwit has always adhered to the concept of cGMP standards and is committed to following high standards of quality management system. The successful on-site inspection by Health Canada is another milestone achievement by Viwit as a world-leading pharmaceutical and health company. Viwit will continue to follow the cGMP standards for each operation procedure to provide the market with safer and higher quality products.

Welcome participants in CPhI Worldwide 2018, booth number: 7A80 2018-10-09 01:33:00

CPhI Worldwide 2018 will be held on October 9-11, 2018 at the Madrid International Convention and Exhibition Center in Spain. Welcome to patronage of Viwit, booth number: 7A80. If you want to make an appointment in advance, please send an email to service@viwit.com

Eletriptan intermediate

【Alias】 Eletriptan intermediate
【Catalogue Number】AP0701
【CAS #】 143322-57-0
【Molecular Formula】 C14H17BrN2
【Molecular Weight】293.2

English Name : Eletriptan intermediate

CAS# : 143322-57-0





产品描述

Parameters

Alias	Eletriptan intermediate
Catalog Number	AP0701
CAS #	143322-57-0
Molecular Formula	C₁₄H₁₇BrN₂
Molecular Weight	293.2
Structural Formula
Product Introduction CAS 143322-57-0	(R) -5-Bromo-3- (1-methyl-2-pyrrolidinylmethyl) -1H-indole, English name is (R) -5-Bromo-3- [ (1-methyl-2-pyrrolidinyl) methyl] -1H-indole, U.S. Chemical Abstracts Registry number is cas 143322-57-0. This product (cas 143322-57-0) is an intermediate of eletriptan. Eletriptan is a selective 5-HT receptor agonist that causes intracranial vasoconstriction by activating intracranial blood vessels (including arteriovenous anastomosis) and 5-HTIB / ID receptors on sympathetic nerves of the trigeminal nervous system And inhibit the release of pro-inflammatory neuropeptides. For the treatment of adult aura or non-aura migraine

Scan the QR code to read on your phone

Previous

Cinacalcet Hydrochloride Intermediate 585-50-2

Next

Cyclen 294-90-6



search

Confirm

Close

About Us

R&D and Innovation

Products

Innovation

Sustainable

News Center

Join Us

Contact Us

VIWIT 沪ICP备12014533号-2

EN

中文